Medtronic plc (MDT) Institutional Ownership & Insider Trading

2,125 institutions reported holding Medtronic plc shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 18 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

MDTMedtronic plcFollow MDT — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 122.0B
P/E TTM: 23.4
Dividend yield: 3.0%
52-week: —
Next earnings: 16 Nov, in 23 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

2,125 institutions held 86.5% of the shares. Across filers that reported both quarters, shares held changed -0.5%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	2,125	1106	-0.5%	767	118	817	207
Mar 26	2,204	1094	+1.7%	753	111	722	171
Dec 25	2,246	1093	-4.3%	694	120	701	75
Sep 25	2,118	1125	+4.6%	707	133	652	91
Jun 25	2,089	1078	+0.4%	719	84	706	121
Mar 25	2,109	1059	+1.2%	796	143	653	89
Dec 24	2,047	1062	-1.9%	655	71	739	127
Sep 24	1,997	1034	-3.8%	607	123	751	91

Medtronic plc — questions

Who owns Medtronic plc stock?: 2,125 institutions reported Medtronic plc shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.9%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), STATE STREET CORP (5.0%).
Are Medtronic plc insiders buying or selling?: 18 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Medtronic plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.